All News #Library
Others
EuMentis Gets FDA Clearance for Schizophrenia IND Application
30 Jul 2025 //
PR NEWSWIRE
EuMentis Announces the First Closing of a Targeted $40M Series B Financing
15 Feb 2023 //
GLOBENEWSWIRE
EuMentis Receives $3M Award from US DoD to Advance NMDA Receptor Antagonist
08 Feb 2023 //
GLOBENEWSWIRE

Market Place
Sourcing Support